These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28481772)

  • 1. HIV drug resistance in Africa: an emerging problem that deserves urgent attention.
    Moreno M; Caballero E; Mateus RM; Samba F; Gil E; Falcó V
    AIDS; 2017 Jul; 31(11):1637-1639. PubMed ID: 28481772
    [No Abstract]   [Full Text] [Related]  

  • 2. New insights into HIV resistance testing: nursing guidelines and implications.
    Kirton CA; Kurtyka D; Sterken DJ
    J Assoc Nurses AIDS Care; 2007; 18(3):74-86. PubMed ID: 17570302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment options after virological failure of first-line tenofovir-based regimens in South Africa: an analysis by deep sequencing.
    Casadellà M; Noguera-Julian M; Sunpath H; Gordon M; Rodriguez C; Parera M; Kuritzkes DR; Marconi VC; Paredes R
    AIDS; 2016 Apr; 30(7):1137-40. PubMed ID: 26807968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral patterns of unboosted 908 identified.
    AIDS Patient Care STDS; 2003 Aug; 17(8):431. PubMed ID: 13678545
    [No Abstract]   [Full Text] [Related]  

  • 5. HIV drug resistance testing: an update for the clinician.
    Rice HL; Zolopa AR
    AIDS Clin Care; 2001 Oct; 13(10):89-91, 94-6, 100. PubMed ID: 11590921
    [No Abstract]   [Full Text] [Related]  

  • 6. Slow accumulation of HIV resistance mutations: implications for resource-limited settings?
    Stevens WS
    J Infect Dis; 2009 Sep; 200(5):670-2. PubMed ID: 19604045
    [No Abstract]   [Full Text] [Related]  

  • 7. Report from the 4th International Workshop on HIV Drug Resistance and Treatment Strategies.
    O'Brien W
    Res Initiat Treat Action; 2000 Sep; 6(3):26-9. PubMed ID: 11708164
    [No Abstract]   [Full Text] [Related]  

  • 8. The benefits of HIV resistance testing in optimizing drug discovery.
    Heilek-Snyder G; Bean P
    Am Clin Lab; 2002 Oct; 21(8):13-4. PubMed ID: 12440169
    [No Abstract]   [Full Text] [Related]  

  • 9. HIV Drug Resistance Testing in a Resource Limited Setting with High Viral Diversity: The First Twenty Eight Months Experience.
    Ngo-Malabo ET; Ngoupo PA; Sadeuh-Mba SA; Akongnwi E; Banaï R; Ngono L; Bilong-Bilong CF; Kfutwah A; Njouom R
    Curr HIV Res; 2017; 15(4):297-305. PubMed ID: 28745207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Resistance investigations during HIV-therapy is necessary].
    Schattenfroh S
    Dtsch Med Wochenschr; 1998 Feb; 123(7):A7. PubMed ID: 9505940
    [No Abstract]   [Full Text] [Related]  

  • 11. Dried blood spots for HIV-1 drug resistance genotyping in decentralized settings in Senegal.
    Diouara AA; Diop-Ndiaye H; Kebe-Fall K; Tchiakpè E; Ndiaye O; Ayouba A; Peeters M; Mboup S; Kane CT
    J Med Virol; 2014 Jan; 86(1):45-51. PubMed ID: 24122937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV and drug resistance - interpretation and therapeutic progress.
    Gürtler L
    Intervirology; 2012; 55(2):77-8. PubMed ID: 22286873
    [No Abstract]   [Full Text] [Related]  

  • 13. Report from the XV International HIV Drug Resistance Workshop.
    Kuritzkes DR
    AIDS Clin Care; 2006 Sep; 18(9):83-4. PubMed ID: 16995272
    [No Abstract]   [Full Text] [Related]  

  • 14. Ultradeep sequencing in the therapeutic management of HIV-1 infection at treatment initiation.
    Todesco E; Mercier-Darty M; Jung M; Bottero J; Boyd A; Marcelin AG; Calvez V; Morand-Joubert L
    J Antimicrob Chemother; 2015; 70(6):1919-20. PubMed ID: 25637517
    [No Abstract]   [Full Text] [Related]  

  • 15. [Incorporation of the test of resistance to antiretroviral drugs in clinical practice].
    Soriano V; Briones C
    Med Clin (Barc); 1999 Mar; 112(11):412-5. PubMed ID: 10231774
    [No Abstract]   [Full Text] [Related]  

  • 16. Detection and significance of minority quasispecies of drug-resistant HIV-1.
    Metzner KJ
    J HIV Ther; 2006 Dec; 11(4):74-81. PubMed ID: 17578210
    [No Abstract]   [Full Text] [Related]  

  • 17. Predicting antiretroviral drug resistance from the latest or the cumulative genotype.
    Garcia F; Alvarez M; Fox Z; Garcia-Diaz A; Guillot V; Johnson M; Chueca N; Phillips A; Hernández-Quero J; Geretti AM
    Antivir Ther; 2011; 16(3):373-82. PubMed ID: 21555820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are resistance puzzlers caught in a data quagmire? XIV International HIV Drug Resistance Workshop. June 7-11, 2005, Quebec, Canada.
    Mascolini M
    IAPAC Mon; 2005 Sep; 11(9):256-64, 267-75. PubMed ID: 16363042
    [No Abstract]   [Full Text] [Related]  

  • 19. HIV drug resistance testing: data be damned.
    Res Initiat Treat Action; 2000 Dec; 6(4):25-7. PubMed ID: 11708172
    [No Abstract]   [Full Text] [Related]  

  • 20. Resistance to antiretroviral drugs in newly diagnosed, young treatment-naïve HIV-positive pregnant women in the province of KwaZulu-Natal, South Africa.
    Parboosing R; Naidoo A; Gordon M; Taylor M; Vella V
    J Med Virol; 2011 Sep; 83(9):1508-13. PubMed ID: 21739439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.